Intensive Care Unit clinical trials

Explore recruiting intensive care unit clinical trials.

Recruiting intensive care unit studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Intensive Care Unit trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Comparison of an inhaled sedation strategy with an intravenous sedation strategy in intensive care patients treated with invasive mechanical ventilation: INASED study

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

STRAtified Dosing based on Augmented renal clearance for CEFtriaxone in patients with severe community-acquired pneumonia: the STRADA-CEF trial

Belgium

Therapeutic use (Phase IV) EU CTIS Study details

Opioid-Free Analgesia In Intensive Care Unit : A Prospective, Monocentric, Randomized, Double-Blind, Feasibility Clinical Trial

France

Therapeutic use (Phase IV) EU CTIS Study details

A Randomized, Parallel, Open-Label, Phase 1/2a Study to Assess the Safety and Tolerability of Multiple Doses of the Bacteriophage Cocktail TP-122 (Component TP-122A), for the Treatment of Ventilator-Associated Pneumonia

Portugal, Netherlands

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Pregnancy Outcomes: Effects of Metformin Study (POEM Study) a long term randomized controlled parallel group study in gestational diabetes mellitus

Netherlands

Therapeutic confirmatory (Phase III) EU CTIS Study details

A single-centre, partially blind, randomised, parallel-group, two-arms, superiority study to compare the efficacy and safety of extended (3 h) and intermittent infusion (0.5 h) of β-lactams (cefepime, ceftriaxone, meropenem, piperacillin/tazobactam) in critically ill paediatric patients (PEBBLE)

Hungary

Therapeutic use (Phase IV) EU CTIS Study details

Intensive Care Unit trials by city

Intensive Care Unit in Toronto Intensive Care Unit in Vancouver Intensive Care Unit in Montreal Intensive Care Unit in Calgary Intensive Care Unit in Edmonton Intensive Care Unit in Ottawa Intensive Care Unit in Winnipeg Intensive Care Unit in Quebec City Intensive Care Unit in Hamilton Intensive Care Unit in Kitchener Intensive Care Unit in London Intensive Care Unit in Halifax Intensive Care Unit in New York Intensive Care Unit in Los Angeles Intensive Care Unit in Chicago Intensive Care Unit in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease